MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation ROCE Ratio 2011-2026 | HSKA
Annual ROCE Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.81 | -0.23 | -2.85 | 0.15 | 2.79 | 16.55 | 16.8 | 9.41 | 3.56 | -1.89 | 4.12 | 6.18 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.8 | -4.81 | 4.15 |
Quarterly ROCE Ratio Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.15 | -4.17 | -4.72 | -5.12 | -3.95 | -0.48 | -0.41 | 0.22 | -1.17 | -3.09 | -2.59 | -2.53 | -1.35 | 0.21 | 2.42 | -0.64 | 1.52 | 3.1 | 7.45 | 14.15 | 16.89 | 18.14 | 18.57 | 19.97 | 19.52 | 19.01 | 17.13 | 15.34 | 14.13 | 13.47 | 11.16 | 8.43 | 7.28 | 5.48 | 8.02 | 7.54 | -1.78 | -3.04 | -7.41 | -7.62 | 0.75 | 4.42 | 3.8 | 4.7 | 5.74 | 6.71 | 0.84 | 1.83 | 3.18 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.97 | -7.62 | 4.63 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Medpace Holdings
MEDP
|
116.53 | $ 460.74 | 0.83 % | $ 13.3 B |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
29.32 | $ 9.15 | 1.67 % | $ 610 M | USA |
|
Biodesix
BDSX
|
-41.6 | $ 15.54 | 5.79 % | $ 2.02 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.61 | -1.07 % | $ 427 M | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
National Research Corporation
NRC
|
161.47 | $ 17.44 | -0.4 % | $ 390 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.39 | - | $ 417 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 159.19 | 0.75 % | $ 7.89 B | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 166.09 | -0.52 % | $ 28.6 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.18 | -19.18 % | $ 6.43 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 264.46 | 1.94 % | $ 26.1 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
-365.72 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 125.98 | 1.77 % | $ 20 B | USA |
 |
RadNet
RDNT
|
5.69 | $ 59.87 | -3.03 % | $ 4.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
-52.81 | $ 26.6 | -1.23 % | $ 34.5 M | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.66 | 0.6 % | $ 278 M | USA |
 |
Sotera Health Company
SHC
|
70.91 | $ 13.84 | -0.32 % | $ 3.93 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 102.01 | -4.44 % | $ 4.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 266.12 | 0.64 % | $ 22.1 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 31.34 | -1.2 % | $ 1.59 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 3.46 | -0.57 % | $ 1.86 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 7.86 | -2.96 % | $ 1.01 B | USA |
 |
Neuronetics
STIM
|
-140.48 | $ 1.46 | -9.06 % | $ 96.3 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 194.52 | -2.78 % | $ 19.1 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.84 | 1.59 % | $ 951 M | USA |
 |
OPKO Health
OPK
|
-7.58 | $ 1.13 | -1.74 % | $ 784 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 25.35 | -1.55 % | $ 704 M | USA |
 |
DarioHealth Corp.
DRIO
|
-36.38 | $ 7.76 | 3.47 % | $ 30.9 M | Israel |
 |
DexCom
DXCM
|
33.2 | $ 66.6 | 1.0 % | $ 26 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | $ 104.91 | - | $ 19.8 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 47.49 | 6.72 % | $ 2.84 B | USA |